Cannabis Report
Home > Boards > US OTC > Cannabis >

Cannabics Pharmaceuticals Inc. (CNBX)

Add CNBX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 8/17/2018 5:34:50 PM - Followers: 154 - Board type: Free - Posts Today: 0


***4/12/2017 NEWS UPDATE*** 

FORBES.COM:  CNBX Added To The U.S. Marijuana Index

***4/7/2017 NEWS UPDATE*** 

Reports Success From Recent Cannabis Study On Cancer


***4/3/2017 NEWS UPDATE*** 

Cannabics Pharmaceuticals Inc. Receives the Final Report of Its
Research on Antitumor Properties of Cannabinoids Held in Israel

Itamar Borochov, CEO of Cannabics Pharmaceuticals said, "The results from this research strengthen our vision of creating anticancer treatments based on natural cannabis medicine".


Bringing Cannabinoid Diagnostics to Personalized Cancer Care

Cannabics Pharmaceuticals Inc. (CNBX), a U.S-based public company, is dedicated to the development of personalized diagnostic tools, aimed to provide supportive data for practitioners and patients regarding cannabinoid based therapy. The Company’s R&D is based in Israel, where it is licensed by the Ministry of Health for its work in both scientific and clinical research. The Company’s focus is on harnessing the therapeutic properties of natural Cannabinoid formulations. Cannabics engages in delivering the maximum amount of supportive data for cancer patients and their doctors, utilizing advanced screening systems and personalized bioinformatics tools.

View entire 24 page presentation :

Cannabics SR' CAPSULES

Long acting oil capsule that provides a safe, effective and reliable administration of cannabis.

Cannabics SR' Capsules, Technology Description - Route of administration
There is a growing number of patients, worldwide, who could benefit from the therapeutic properties of cannabinoids. The unmet need of these patients is a safe, standardized and easy to administer cannabinoid-based therapy. Cannabinoid administration is mainly through smoking, vaporizing, sublingual and oral. While clinical studies show contradictory data regarding a correlation between smoking cannabis and respiratory diseases, most physicians agree that smoking medical cannabis, while having its benefits, is not a healthy nor standardized therapy. 

The pharmacokinetics of THC varies as a function of its route of administration. Pulmonary assimilation of inhaled THC causes a maximum plasma concentration within minutes; psychotropic effects start within seconds to a few minutes, reach a maximum after 15–30 minutes, and taper off within 2–3 hours. Following oral ingestion, psychotropic effects set in with a delay of 30–90 minutes, reach their maximum after 2–3 hours and last for about 4–12 hours, depending on dose and specific effect. Another common route of administration is sublingually. Pure cannabinoids are extracted from the raw plant, dissolved in different oils and administered with a dropper. The beneficial effect of sublingual oil administration is 2-4 hours with a fast onset due to quick absorption through the oral cavity.

The most common oral administration of cannabinoids is through eating edibles, mainly, cookies, chocolate bars and lozenges. Since absorption is attenuated when cannabinoids are ingested orally, Edibles usually contain high dosages of cannabinoids (50-300mg). The high dosage may cause undesirable side effects, mainly, dizziness, anxiety and dissociation. These side effects cause many patients to withdraw from the therapeutic process.  The oral administration route has the longest beneficial effect (4-8 hours) and lacks the undesirable effects of smoking.

Technology currently envisions the licensing of three different formulations: capsules with a 10:1 CBD to THC ratio, a 10:1 THC to CBD ratio and a balanced formulation with 1:1 THC:CBD.

Cannabics Pharmaceuticals Inc. does not manufacture, distribute, dispense or possess any controlled substances, including cannabis or cannabis based preparations. 

Cannabics Pharmaceuticals Announces a New Dosage of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering from Cachexia and Anorexia Syndrome...!

BETHESDA, Maryland, Jan. 3, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) today announced development of Cannabics 5mg THC Capsule intended for naïve patient who have not tried cannabis in the past.

Dr. Eyal Ballan, Chief scientist of Cannabics Pharmaceuticals stated, "Our mission is to find the right balance between efficacy on the one hand and the elimination of undesired psychoactive effects on other."

The Cannabics 5mg THC capsule is currently being evaluated by the company in a clinical study as a palliative treatment, which is conducted by the oncology department at the prestigious Rambam Medical Center in northern Israel and under strict regulations of the Ministry of Health, by whom Cannabics Pharmaceuticals has been licensed since 2014.

The study is taking place in Israel, it is fully registered with the US NIH under "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients", Identifier NCT02359123, and may be found at :

"The majority of our cancer trial patients have no previous experience with Cannabis, hence this recalibration of the THC level may be more amenable. We believe there is a significant potential medical market for our 5mg THC capsule in countries that have now instituted medical cannabis regulations," said Itamar Borochov, CEO of Cannabics Pharmaceuticals Inc.

What is A Cannabinoid?

You’ve heard by now that marijuana is a powerful medicinal herb. But, just how powerful is it? The list of medical benefits for these top 10 cannabinoids seems endless.

Security Details Share Structure
  Market Value1 $72,404,107 a/o Jan 13, 2017
Authorized Shares 900,000,000 a/o Dec 30, 2016
Outstanding Shares 107,265,344 a/o Dec 30, 2016
-Restricted 90,368,887 a/o Dec 30, 2016
-Unrestricted 16,896,457 a/o Dec 30, 2016
  Held at DTC Not Available
Float 14,295,638 a/o Jun 30, 2016
  Par Value 0.0001

CNBX Security Details Share Structure
  Market Value1 $37,994,466 a/o Oct 28, 2016
  Authorized Shares 900,000,000 a/o Jul 09, 2015
  Outstanding Shares 107,026,665 a/o Jun 30, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 18,737,071 a/o Jun 30, 2016
  Par Value 0.0001

Cannabis Report
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CNBX News: Current Report Filing (8-k) 08/14/2018 01:02:03 PM
CNBX News: Quarterly Report (10-q) 07/16/2018 08:08:21 AM
CNBX News: Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) 06/01/2018 04:33:57 PM
CNBX News: Prospectus Filed Pursuant to Rule 424(b)(2) (424b2) 05/31/2018 04:36:02 PM
CNBX News: Current Report Filing (8-k) 05/02/2018 09:38:58 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#3376   The link scuba2 proveded, cnbx was trying the ChuckG1 08/17/18 05:34:49 PM
#3375   I’m not sure what to make of the Midnightmatt 08/17/18 03:54:23 AM
#3374   I don't believe it is a revenue stream SBZRUS 08/16/18 08:34:58 PM
#3373   Why don't you look at it as a Scuba2 08/16/18 07:32:09 PM
#3372   Thank you Scuba2!! jim992 08/16/18 07:31:36 PM
#3371   The Seedo deal seems to be a bad signal. jon konly 08/16/18 07:27:00 PM
#3370   Link to interview BNN Bloomberg Scuba2 08/16/18 05:01:15 PM
#3369   Please provide a link to the interview if jim992 08/16/18 03:33:40 PM
#3368   Can you post a link to that interview? SBZRUS 08/16/18 03:29:35 PM
#3367   Hi Scuba2, jim992 08/16/18 03:27:26 PM
#3366   Hey Jim Relax The shows are still on. Today the Scuba2 08/16/18 02:54:23 PM
#3365   Hi ChuckG1, jim992 08/16/18 02:16:22 PM
#3364   Easy answer 5MM in orders. Scuba2 08/15/18 11:32:26 PM
#3363   Why is Cannabics buying so much Seedo stock? SBZRUS 08/15/18 10:00:24 PM
#3362   On Post 3293 of 3368 you mention. ChuckG1 08/15/18 11:39:19 AM
#3361   Hi st007, jim992 08/14/18 11:12:57 PM
#3360   Hi ChuckG1, jim992 08/14/18 11:08:46 PM
#3359   Yes, when you hover over they 3 yr st007 08/14/18 11:02:53 PM
#3358   Hi Surfgreen, jim992 08/14/18 10:56:33 PM
#3357   Hi St007, jim992 08/14/18 10:50:56 PM
#3356   Hi Jim, st007 08/14/18 10:27:26 PM
#3355   Jim Thanks so much for your insight. I really surfgreen 08/14/18 04:42:24 PM
#3354   Peeps are loading here surfgreen 08/14/18 11:38:10 AM
#3353   Seedo. SBZRUS 08/14/18 10:45:25 AM
#3352   I wonder if it will meander its way ChuckG1 08/14/18 10:42:12 AM
#3351   NEWS If you will notice this quote ChuckG1 08/14/18 10:14:23 AM
#3350   Some more great news from CNBX Scuba2 08/14/18 10:11:55 AM
#3349   FYI: Post 3348 has information/points of interest and jim992 08/13/18 11:13:38 PM
#3348   Hi Surfgreen, jim992 08/13/18 10:50:44 PM
#3347   Might have been just a punt. Never know ChuckG1 08/13/18 04:28:35 PM
#3346   Might have been just a punt. Never know ChuckG1 08/13/18 04:28:35 PM
#3345   All coiled up and ready to go .... Scuba2 08/13/18 02:19:24 PM
#3344   I'm still waiting.. SBZRUS 08/13/18 02:13:44 PM
#3343   $CNBX$ back in @.75 surfgreen 08/13/18 12:31:19 PM
#3342   Jim- Any idea when the cachexia results will surfgreen 08/12/18 11:25:35 AM
#3341   Thank you for the photo and the news jim992 08/11/18 06:52:06 PM
#3340 Scuba2 08/11/18 08:09:58 AM
#3339 Scuba2 08/11/18 08:08:07 AM
#3338   Yeah, the sector is turning around. About to cnote420 08/08/18 08:49:22 PM
#3337   Both of my MMJ stocks closed green today. jim992 08/08/18 05:57:21 PM
#3336   Was there a new letter to shareholders this jim992 08/06/18 07:38:02 PM
#3335   More cancer news Scuba2 08/04/18 08:07:28 AM
#3334   Here is the letter to shareholders: jim992 08/02/18 10:34:12 PM
#3333   Their new website looks great. Everyone should subscribe Midnightmatt 08/02/18 09:48:15 PM
#3332   Letter to shareholder's out on Etrade st007 08/02/18 02:15:25 PM
#3331   Yes time to get known. :) retired early 08/02/18 12:32:49 PM
#3330   Follow cannabics Pharmaceuticals on Linkedln . Scuba2 08/01/18 03:49:58 PM
#3329   I think this is the bottom. Way oversold. Scuba2 08/01/18 03:04:26 PM
#3328   I'm in. Little yesterday, little today. Will keep BOOYA! 08/01/18 03:02:21 PM
#3327   My patience has paid off and finally able smarty1212 08/01/18 02:49:35 PM